A six-weekly dosing schedule for pembrolizumab in patients with cancer based on evaluation using modelling and simulation

Published 2020 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
A six-weekly dosing schedule for pembrolizumab in patients with cancer based on evaluation using modelling and simulation
Authors
Keywords
Anti-PD-1, Immunotherapy, Modelling, Pembrolizumab, Dosing, Pharmacokinetics
Journal
EUROPEAN JOURNAL OF CANCER
Volume 131, Issue -, Pages 68-75
Publisher
Elsevier BV
Online
2020-04-15
DOI
10.1016/j.ejca.2020.02.016

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.